Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims data.
about
Medication nonadherence in Parkinson's diseaseCost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France.Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysisRole and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease.Medication management and neuropsychological performance in Parkinson's diseaseDevelopment and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx)Prospective memory deficits are associated with poorer everyday functioning in Parkinson's disease.Compliance with pharmacotherapy and direct healthcare costs in patients with Parkinson's disease: a retrospective claims database analysis.Medication Therapy Management Service for Patients with Parkinson's Disease: A Before-and-After Study.Medication adherence in patients with Parkinson's disease.Estimating the direct and indirect costs associated with Parkinson's disease.Drug and treatment costs in Parkinson's disease patients in Sweden.Initiation of medications for Parkinson's disease: a qualitative description.Machine learning classification of medication adherence in patients with movement disorders using non-wearable sensors.Pramipexole and its extended release formulation for Parkinson's disease.Using Medical Claims Analyses to Understand Interventions for Parkinson Patients.Economic impact of medication non-adherence by disease groups: a systematic review.Objective Assessment of Bradykinesia Estimated from the Wrist Extension in Older Adults and Patients with Parkinson's Disease.Pillbox use, satisfaction, and effectiveness among persons with chronic health conditions.
P2860
Q26823300-2B444AAF-1723-40DA-94FF-02FE52B2DE47Q33942472-2A45412E-0769-446C-8F65-56F10EF8DAAAQ35235484-48B898CB-BB5E-4A19-8FD8-928E9E728A17Q35885133-AA68C7A4-F6D2-47B5-BC19-DA913B4DE743Q36822919-5613B2DC-27AE-42BB-8A8E-E3DC2BE4D076Q36944738-6A6B6BEE-47EA-4F5C-997C-78FB2A78DD47Q36972413-7520461F-78EE-42FE-8C6B-42B1EB85E801Q37028983-E74893AA-A1CF-43C4-8F8D-DF5D3227B82AQ37033702-984C3EBA-5109-4F5F-8902-08F8E789415CQ38287369-E0AC5014-7958-4519-81A9-B7917460E84EQ38618871-8FA0783A-FA97-488E-B404-54A1CC9461E7Q39763335-21EDEB69-6A77-473D-890A-CC1273B81E2CQ40485299-C801E7A5-B99D-4002-B8EC-BF8EFF90AF56Q40501135-D511C3F4-94E6-4F04-B85A-2B52B9A367D5Q41021587-D5C6E57B-AAA0-4A0E-AD19-ABD19CE37456Q47288856-EA327970-8388-48EF-8FB2-866AF5802FD3Q47555825-089EEACD-C795-497B-A27A-0FA9DC91B772Q47740248-9EC74F53-C90A-486A-B224-71D0922C37A4Q49019739-BD8E9FF0-5938-4518-A1C0-F169D8305560
P2860
Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims data.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prevalence and cost of medicat ...... om administrative claims data.
@ast
Prevalence and cost of medicat ...... om administrative claims data.
@en
Prevalence and cost of medicat ...... om administrative claims data.
@nl
type
label
Prevalence and cost of medicat ...... om administrative claims data.
@ast
Prevalence and cost of medicat ...... om administrative claims data.
@en
Prevalence and cost of medicat ...... om administrative claims data.
@nl
prefLabel
Prevalence and cost of medicat ...... om administrative claims data.
@ast
Prevalence and cost of medicat ...... om administrative claims data.
@en
Prevalence and cost of medicat ...... om administrative claims data.
@nl
P2093
P2860
P356
P1433
P1476
Prevalence and cost of medicat ...... om administrative claims data.
@en
P2093
Heather M Edin
Jeffery K Allen
Keith L Davis
P2860
P304
P356
10.1002/MDS.22999
P407
P577
2010-03-01T00:00:00Z